According to the ACC/American Heart Association (AHA) guideline, all adults should undergo cholesterol screening to help assess long-term cardiovascular risk. 5,6 Serum LDL-C levels <100 mg/dL are ...

Catheter-based closure of the left atrial appendage (LAA) was found to be not noninferior to physician-directed best medical care for the primary composite endpoint of stroke, systemic embolism, major ...

The American College of Cardiology is pleased to offer fellows in training, medical residents, doctoral or medical students and Cardiovascular Team students (nurses, pharmacists, PAs, and ...

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options ...

Consumption of ultra-processed foods, such as sugar-sweetened beverages, potato chips and packaged cookies, may be associated with adverse health outcomes, according to research being presented at the ...

The Health Equity Heat Map developed by the American College of Cardiology (ACC) is a population health map that leverages location-based metrics to examine the demographics of local communities ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation ...

I am honored to serve as the new Chair of this dynamic community, and I am excited to work alongside all of you. As cardiovascular professionals dedicated to advancing our field, our collective ...

People who use e-cigarettes are significantly more likely to develop heart failure compared with those who have never used them, according to one of the largest prospective studies to date ...

2013 ASCVD Pooled Cohort Equations (PCE), which calculate 10‑year and lifetime risk of atherosclerotic cardiovascular disease using age, sex, race, blood pressure, cholesterol profile, diabetes status ...

As wearable technology with health features becomes increasingly popular, people are taking a more active role in their care journey and collaborating along with their clinicians to establish a plan ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...